Conclusion

Placenta accreta spectrum, uterine fibroids, and revision surgery in patients with postoperative bleeding appear to predict autotransfusion with ICS during cesarean section. In these contexts, as in situations where transfusion difficulties are expected, the use of ICS should be anticipated to reduce the need for homologous transfusion in these young women. In case of rhesus incompatibility, it should be performed along with the preventive injection of Rh immune globulin.
Although severe PPH occurs frequently during cesarean section, most instances occur during vaginal delivery. The use of ICS during cesarean section is widespread, but its use for vaginal delivery is still under consideration because of concerns about infection and feasibility. In the future, salvage of vaginal bleeding with autotransfusion may lead to real changes in the management of PPH and accelerate the inclusion of ICS devices in the maternity ward.